These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12614976)

  • 1. Treatment of onychomycosis in the diabetic patient population.
    Robbins JM
    J Diabetes Complications; 2003; 17(2):98-104. PubMed ID: 12614976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes.
    Seebacher C; Nietsch KH; Ulbricht HM
    Cutis; 2001 Aug; 68(2 Suppl):17-22. PubMed ID: 11665724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciclopirox 8% nail lacquer topical solution for the treatment of onychomycosis in patients with diabetes: a multicenter, open-label study.
    Brenner MA; Harkless LB; Mendicino RW; Page JC
    J Am Podiatr Med Assoc; 2007; 97(3):195-202. PubMed ID: 17507527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciclopirox nail lacquer solution 8% in the 21st century.
    Gupta AK; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S96-102. PubMed ID: 11051138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK; Fleckman P; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciclopirox nail lacquer: a brush with onychomycosis.
    Gupta AK
    Cutis; 2001 Aug; 68(2 Suppl):13-6. PubMed ID: 11665723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciclopirox nail lacquer 8% for the treatment of onychomycosis: a Canadian perspective.
    Gupta AK; Schouten JR; Lynch LE
    Skin Therapy Lett; 2005 Sep; 10(7):1-3. PubMed ID: 16292454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and management of onychomycosis in diabetic patients.
    Gupta AK; Humke S
    Eur J Dermatol; 2000; 10(5):379-84. PubMed ID: 10882947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciclopirox nail lacquer and podiatric practice.
    Gupta AK; Malkin KF
    J Am Podiatr Med Assoc; 2000; 90(10):502-7. PubMed ID: 11107711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical and surgical treatment of onychomycosis.
    Cohen PR; Scher RK
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S74-7. PubMed ID: 8077513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onychomycosis and diabetes.
    Cathcart S; Cantrell W; Elewski Be
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1119-22. PubMed ID: 19309423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common fungal infections of the feet in patients with diabetes mellitus.
    Tan JS; Joseph WS
    Drugs Aging; 2004; 21(2):101-12. PubMed ID: 14960127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
    Pollak RA
    J Am Podiatr Med Assoc; 2014 Nov; 104(6):568-73. PubMed ID: 25514267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of onychomycosis with ciclopirox nail lacquer: a case report.
    Galitz J
    Cutis; 2001 Aug; 68(2 Suppl):23-4. PubMed ID: 11665725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
    Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
    J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of onychomycosis: pros and cons of antifungal agents.
    Gupta AK; Ryder JE; Skinner AR
    J Cutan Med Surg; 2004; 8(1):25-30. PubMed ID: 15688097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
    Baran R; Kaoukhov A
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):21-9. PubMed ID: 15649187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States.
    Gupta AK; Joseph WS
    J Am Podiatr Med Assoc; 2000; 90(10):495-501. PubMed ID: 11107710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal agents for onychomycosis: new treatment strategies to improve safety.
    Zane LT; Chanda S; Coronado D; Del Rosso J
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.